FDA inspection
Dottikon Exclusive Synthesis AG: FDA inspection ending Dec 16, 2022
FDA inspection 1194879 · Voluntary Action Indicated (VAI) · Dottikon
Key facts
| Inspection ID | 1194879 |
|---|---|
| Firm | Dottikon Exclusive Synthesis AG |
| FEI number | 3002806909 |
| Address | Hembrunnstrasse 17 |
| City | Dottikon |
| Country | Switzerland |
| Fiscal year | 2023 |
| Inspection end date | Dec 16, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data